Most Kiwi pharmacists will have heard of products such as Pamol and Eltroxin, but they may not be aware of the company behind these popular brands – Aspen Pharmacare New Zealand
The prospect of medicinal cannabis products being sold on pharmacy shelves may become a reality as early as next year, following last year’s passing of the Misuse of Drugs (Medicinal Cannabis) Amendment Act.
The successful launch of a new product in the challenging but lucrative Chinese market scooped milk protein company Quantec the top prize at the Natural Health Products New Zealand awards last night
Ten pharmacies across New Zealand have signed up to a virtual general practice service, that is meeting a range of health needs, from emergency prescriptions to contraception and sexual health
Green Cross Health chair Peter Merton says the Government should review the $5 prescription charge to ensure it supports current equity of access healthcare policies
The first-ever launch of a medicinal cannabis company, CannaSouth, on the New Zealand Stock exchange met its’ financial goal, but shortly afterwards its share price fell by 20 per cent
Since the Misuse of Drugs (Medicinal Cannabis) Amendment Act was passed last December, the clock has been ticking on the setting of rules for commercial medicinal cannabis production. Simon Maude visits one of the leading start-ups hoping to catch the green wave
The half-year financial results for Ebos quickly proved unpopular with the market, prompting a drop in the Christchurch-based pharmaceutical and animal meds wholesaler's share price
Academic pharmacist Nataly Martini provides key information on Helicobacter pylori pathophysiology, diagnosis and evidence-based treatment strategies to enhance patient outcomes